Home › Bronchiolitis Obliterans Syndrome › Massachusetts › Boston
Bronchiolitis Obliterans Syndrome clinical trials in Boston, MA
13 studies for Bronchiolitis Obliterans Syndrome are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Axatilimab for Sclerotic Chronic Graft-versus-Host Disease
RecruitingPhase 2
- Dana-Farber Cancer Institute, Boston
A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)
RecruitingPhase 2
- Dana-Farber Cancer Institute- Site Number : 8400007, Boston
Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease
RecruitingPhase 2
- Dana-Farber Cancer Institute, Boston
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
RecruitingPhase 3
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
RecruitingObservational study
- Massachusetts Cancer Research Center, Boston
Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic GVHD
RecruitingPhase 1
- Dana-Farber Cancer Institute, Boston
Plasma and Radiologic Biomarkers of Response to ECP in Lung Transplant Recipients With CLAD
RecruitingObservational study
- Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
RecruitingPhase 2
- Massachusetts General Hospital, Boston
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
RecruitingPhase 2
- Dana-Farber Cancer Institute, Boston
- Boston Children's Hospital, Boston
- Brigham and Women's Hospital, Boston
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
RecruitingPhase 3
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial
Recruiting
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
RecruitingPhase 2
- Dana-Farber Cancer Institute, Boston
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
RecruitingPhase 1
- Dana-Farber Cancer Institute, Boston
Bronchiolitis Obliterans Syndrome trials in other cities
- Seattle, WA11 studies
- Atlanta, GA10 studies
- New York City, NY9 studies
- Houston, TX8 studies
- Los Angeles, CA7 studies
- Miami, FL7 studies
- Tampa, FL6 studies
- Durham, NC6 studies
- Baldwin Park, CA6 studies
- Washington, DC6 studies
- Philadelphia, PA6 studies
- Chicago, IL5 studies
Other studies in Boston
- Breast Cancer111 studies
- Non-Small Cell Lung Cancer90 studies
- Cancer (all types)86 studies
- Colorectal Cancer63 studies
- Metastatic Cancer63 studies
- Lung Cancer62 studies
- Ovarian Cancer61 studies
- Prostate Cancer59 studies
- Depression52 studies
- Endometrial Cancer50 studies
- Heart Failure44 studies
- Acute Myeloid Leukemia44 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.